A systematic review comparing outcomes of surgical resection and non-surgical treatments for patients with hepatocellular carcinoma and portal vein tumor thrombus-Reference-Cited by-同舟云学术

A systematic review comparing outcomes of surgical resection and non-surgical treatments for patients with hepatocellular carcinoma and portal vein tumor thrombus

Published:2018-12 Issue:12 Volume:20 Page:1119-1129
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Liang Lei,Chen Ting-Hao,Li Chao,Xing Hao,Han Jun,Wang Ming-Da,Zhang Han,Lau Wan Yee,Wu Meng-Chao,Shen Feng,Yang Tian

Funder

National Natural Science Foundation of China

Shanghai Pujiang Program

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference41 articles.

1. Global cancer statistics;Jemal;CA A Cancer J Clin,2011

2. Primary liver cancer: worldwide incidence and trends;Bosch;Gastroenterology,2004

3. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials;Llovet;Hepatology,1999

4. Hepatocellular carcinoma in Central Europe: prognostic features and survival;Schoniger-Hekele;Gut,2001

5. Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus;Minagawa;World J Gastroenterol,2006

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition);Liver Research;2024-06

2. Surgical outcome and risk scoring to predict survival after hepatic resection for hepatocellular carcinoma with portal vein tumor thrombosis;Annals of Hepato-Biliary-Pancreatic Surgery;2024-05-09

3. Transarterial chemoembolization (TACE)-hepatic arterial infusion chemotherapy (HAIC) combined with PD-1 inhibitors plus lenvatinib as a preoperative conversion therapy for nonmetastatic advanced hepatocellular carcinoma: a single center experience;Translational Cancer Research;2024-05

4. Long-term surgical outcomes of bile duct tumor thrombus versus portal vein tumor thrombus for hepatocellular carcinoma: a propensity score matching analysis;Frontiers in Oncology;2024-04-02

5. Sintilimab, bevacizumab biosimilar, and HAIC for unresectable hepatocellular carcinoma conversion therapy: a prospective, single-arm phase II trial;Neoplasma;2024